Genomic Applications Partnership Program (GAPP) – 2025
As part of the Canadian Genomics Strategy (CGS), the Genomic Applications Partnership Program (GAPP) supports Canadian for-profit enterprises looking to commercialize their idea or research by:
Increasing Canadian private-sector investment in the commercialization of innovation derived from public R&D funding in genomics and biotechnology.
Stimulating technological innovation and implementation through co-operative R&D between research and receptors.
Enabling research investments that de-risk opportunities and secure follow-on funding from finance and industry.
Fostering and encouraging participation in innovation and entrepreneurship by individuals from equity-deserving communities.
